Atlanta, GA, United States of America

Jing Chen

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jing Chen

Introduction

Jing Chen is a notable inventor based in Atlanta, GA (US), recognized for his significant contributions to the field of cancer treatment. With a total of 4 patents, his work focuses on innovative methods and compounds that aim to improve therapeutic outcomes for patients suffering from various types of cancer.

Latest Patents

Among his latest patents, one notable invention is related to dehydroacetic acid (DHAA) and its derivatives for uses in treating cancer. This patent outlines methods for managing or treating cancer by utilizing agents that lower circulating acetoacetate levels. These agents include hypolipidemic agents or other compounds that can antagonize acetoacetate-BRAF V600 mutant binding, thereby attenuating BRAF V600 mutant tumor growth. The patent emphasizes the administration of an effective amount of dehydroacetic acid, its derivatives, prodrugs, or salts to subjects in need of treatment.

Another significant patent involves PGAM1 inhibitors and methods related to their use in treating or preventing PGAM1 mediated conditions, such as cancer or tumor growth. This disclosure highlights the administration of effective amounts of PGAM1 inhibitors, including anthracene-9,10-dione derivatives, to subjects requiring treatment. The methods described in this patent are particularly relevant for conditions like lung cancer, head and neck cancer, and leukemia.

Career Highlights

Jing Chen has had a distinguished career, working with prominent institutions such as Emory University and the United States Government as represented by the Department of Veterans Affairs. His research and innovations have contributed significantly to the understanding and treatment of cancer, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Jing Chen has collaborated with esteemed colleagues, including Sumin Kang and Taro Hitosugi. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in cancer treatment.

Conclusion

Jing Chen's contributions to cancer research and treatment through his patents and collaborations highlight his role as a leading inventor in the field. His innovative approaches continue to pave the way for advancements in medical therapies, ultimately benefiting patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…